Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease. B-cell receptor (BCR) pathway is essential for malignant B-cell growth, survival, and proliferation. Various immune cells, including T-cells and macrophages in the tumor microenvironment (TME) contribute to tumor cell survival and pat...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a418c832eb2f477cb6afc86424d80a53 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|